Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalon GloboCare (ALBT) Notes Payables (2019 - 2025)

Historic Notes Payables for Avalon GloboCare (ALBT) over the last 7 years, with Q3 2025 value amounting to $5.8 million.

  • Avalon GloboCare's Notes Payables rose 2286.45% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year increase of 2286.45%. This contributed to the annual value of $5.7 million for FY2024, which is 19688.38% up from last year.
  • Latest data reveals that Avalon GloboCare reported Notes Payables of $5.8 million as of Q3 2025, which was up 2286.45% from $5.8 million recorded in Q2 2025.
  • In the past 5 years, Avalon GloboCare's Notes Payables ranged from a high of $5.8 million in Q3 2023 and a low of $390000.0 during Q1 2021
  • For the 5-year period, Avalon GloboCare's Notes Payables averaged around $3.2 million, with its median value being $4.6 million (2022).
  • Its Notes Payables has fluctuated over the past 5 years, first soared by 113076.92% in 2022, then tumbled by 5989.28% in 2023.
  • Avalon GloboCare's Notes Payables (Quarter) stood at $390000.0 in 2021, then soared by 1130.77% to $4.8 million in 2022, then tumbled by 59.89% to $1.9 million in 2023, then surged by 196.88% to $5.7 million in 2024, then increased by 1.44% to $5.8 million in 2025.
  • Its Notes Payables stands at $5.8 million for Q3 2025, versus $5.8 million for Q2 2025 and $5.7 million for Q1 2025.